Ryan M. Bartolucci Sells 6,059 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CAO Ryan M. Bartolucci sold 6,059 shares of the business's stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $80.00, for a total value of $484,720.00. Following the completion of the sale, the chief accounting officer now owns 47,000 shares in the company, valued at $3,760,000. This represents a 11.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Tempus AI Price Performance

Shares of TEM stock traded up $5.69 during trading on Friday, hitting $89.44. The company had a trading volume of 25,048,636 shares, compared to its average volume of 12,947,475. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The stock's 50-day moving average is $46.60 and its two-hundred day moving average is $50.29. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45.

Analysts Set New Price Targets

TEM has been the topic of a number of research reports. Piper Sandler restated a "neutral" rating and issued a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Loop Capital decreased their price target on Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research report on Tuesday, January 14th. Wolfe Research began coverage on Tempus AI in a research report on Friday, December 13th. They set an "outperform" rating and a $60.00 price target on the stock. TD Cowen reiterated a "buy" rating and set a $74.00 price target (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $56.00 price target on shares of Tempus AI in a research report on Tuesday, January 14th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and a consensus price target of $58.55.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Wells Fargo & Company MN boosted its stake in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after buying an additional 278 shares in the last quarter. First Horizon Advisors Inc. purchased a new stake in shares of Tempus AI during the third quarter valued at approximately $30,000. Geode Capital Management LLC boosted its stake in shares of Tempus AI by 0.4% during the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock valued at $7,537,000 after purchasing an additional 539 shares during the period. Operose Advisors LLC purchased a new stake in shares of Tempus AI during the fourth quarter valued at approximately $25,000. Finally, Prestige Wealth Management Group LLC boosted its stake in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after purchasing an additional 965 shares during the period. 24.22% of the stock is currently owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.